MD Anderson Research Highlights for August 25, 2021
Â鶹ӳ» MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include clinical studies to investigate novel treatment strategies, a new understanding of cancer precursor lesions, identifying a calcium signaling receptor, characterizing nodal immune flair after immunotherapy, a community...
CPRIT awards nearly $13 million in support of MD Anderson research
Â鶹ӳ» MD Anderson Cancer Center has been awarded $12.75 million from the Cancer Prevention and Research Institute of Texas...
MD Anderson Research Highlights for August 11, 2021
Â鶹ӳ» MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational...
Researchers discover new factor in preventing phenylketonuria, offering new treatment strategy
Researchers at Â鶹ӳ» MD Anderson Cancer Center have discovered a critical new factor in regulating phenylalanine metabolism and, therefore, in preventing the inherited metabolic disorder phenylketonuria (PKU). The research also suggests a possible avenue for new treatments that may be effective for certain patients with PKU.
The study, published today in Science, demonstrates that the long noncoding RNA (lncRNA...
